Silvia Mappa
Swedish Orphan Biovitrum (Sweden)(SE)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, Acute Myeloid Leukemia Research, CNS Lymphoma Diagnosis and Treatment, Histone Deacetylase Inhibitors Research
Most-Cited Works
- → Chlamydophila Psittaci Eradication With Doxycycline As First-Line Targeted Therapy for Ocular Adnexae Lymphoma: Final Results of an International Phase II Trial(2012)167 cited
- → Salvage chemoimmunotherapy with rituximab, ifosfamide and etoposide (R‐IE regimen) in patients with primary CNS lymphoma relapsed or refractory to high‐dose methotrexate‐based chemotherapy(2012)76 cited
- → Prevalence of Borrelia Burgdorferi Infection in a Series of 98 Primary Cutaneous Lymphomas(2011)66 cited
- → Liposome‐encapsulated doxorubicin in combination with cyclophosphamide, vincristine, prednisone and rituximab in patients with lymphoma and concurrent cardiac diseases or pre‐treated with anthracyclines(2007)63 cited
- → Rituximab and chlorambucil as first-line treatment for low-grade ocular adnexal lymphomas(2007)44 cited
- → A Reappraisal of the Diagnostic and Therapeutic Management of Uncommon Histologies of Primary Ocular Adnexal Lymphoma(2013)43 cited
- → Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents(2020)43 cited
- → Preliminary Results Of a Phase II Study Of Single Agent Bay 80-6946, a Novel PI3K Inhibitor, In Patients With Relapsed/Refractory, Indolent Or Aggressive Lymphoma(2013)35 cited
- → A phase II study of addition of pracinostat to a hypomethylating agent in patients with myelodysplastic syndromes who have not responded to previous hypomethylating agent therapy(2019)17 cited
- → Phase 2A Study of Copanlisib, a Novel PI3K Inhibitor, in Patients with Indolent Lymphoma(2014)17 cited